Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 147

1.

Renal cell carcinoma with rhabdoid features: an aggressive neoplasm with overexpression of p53.

Leroy X, Zini L, Buob D, Ballereau C, Villers A, Aubert S.

Arch Pathol Lab Med. 2007 Jan;131(1):102-6.

PMID:
17227108
[PubMed - indexed for MEDLINE]
2.

Renal cell carcinoma with rhabdoid features. Divergent differentiation of conventional (clear cell) carcinoma.

Klimis T, Karvounis H.

J BUON. 2008 Jul-Sep;13(3):433-6.

PMID:
18979563
[PubMed - indexed for MEDLINE]
3.

[Clinicopathologic study of renal cell carcinoma with rhabdoid features].

Ma J, Zhou XJ, Huang WB, Zhou HB, Jiang SJ, Rao Q, Lu ZF, Shi QL.

Zhonghua Bing Li Xue Za Zhi. 2007 Mar;36(3):166-70. Chinese.

PMID:
17535682
[PubMed - indexed for MEDLINE]
4.

Renal cell carcinoma with rhabdoid features.

Gökden N, Nappi O, Swanson PE, Pfeifer JD, Vollmer RT, Wick MR, Humphrey PA.

Am J Surg Pathol. 2000 Oct;24(10):1329-38.

PMID:
11023094
[PubMed - indexed for MEDLINE]
5.

[Non-metastatic clear cell renal carcinoma: prognostic significance of morphometric and biomolecular factors].

Iurin AG.

Vopr Onkol. 2009;55(2):177-82. Russian.

PMID:
19514371
[PubMed - indexed for MEDLINE]
6.

Renal medullary carcinoma: rhabdoid features and the absence of INI1 expression as markers of aggressive behavior.

Cheng JX, Tretiakova M, Gong C, Mandal S, Krausz T, Taxy JB.

Mod Pathol. 2008 Jun;21(6):647-52. doi: 10.1038/modpathol.2008.44. Epub 2008 Mar 7.

PMID:
18327209
[PubMed - indexed for MEDLINE]
Free Article
7.

Value of p53 as a prognostic marker in histologic subtypes of renal cell carcinoma: a systematic analysis of primary and metastatic tumor tissue.

Zigeuner R, Ratschek M, Rehak P, Schips L, Langner C.

Urology. 2004 Apr;63(4):651-5.

PMID:
15072872
[PubMed - indexed for MEDLINE]
8.

Adult renal cell carcinoma with rhabdoid morphology represents a neoplastic dedifferentiation analogous to sarcomatoid carcinoma.

Chapman-Fredricks JR, Herrera L, Bracho J, Gomez-Fernandez C, Leveillee R, Rey L, Jorda M.

Ann Diagn Pathol. 2011 Oct;15(5):333-7. doi: 10.1016/j.anndiagpath.2011.03.002. Epub 2011 Jun 12.

PMID:
21665507
[PubMed - indexed for MEDLINE]
9.

Renal cell carcinoma with rhabdoid features: an aggressive neoplasm.

Kuroiwa K, Kinoshita Y, Shiratsuchi H, Oshiro Y, Tamiya S, Oda Y, Naito S, Tsuneyoshi M.

Histopathology. 2002 Dec;41(6):538-48.

PMID:
12460207
[PubMed - indexed for MEDLINE]
10.

Sarcomatoid renal cell carcinoma with rhabdoid features.

Al-Saidi NA, Akhtar M.

Ann Saudi Med. 2013 Sep-Oct;33(5):495-9. doi: 10.5144/0256-4947.2013.495.

PMID:
24188946
[PubMed - indexed for MEDLINE]
11.

Nuclear p53 overexpression in bladder, prostate, and renal carcinomas.

Sinik Z, Alkibay T, Ataoglu O, Biri H, Sözen S, Deniz N, Karaoglan U, Bozkirli I.

Int J Urol. 1997 Nov;4(6):546-51.

PMID:
9477181
[PubMed - indexed for MEDLINE]
12.

Is Stat3 and/or p53 mRNA expression a prognostic marker for renal cell carcinoma?

Masuda A, Kamai T, Abe H, Arai K, Yoshida K.

Biomed Res. 2009 Jun;30(3):171-6.

PMID:
19574718
[PubMed - indexed for MEDLINE]
Free Article
13.

Expression of p53 and bcl-2 in primary locally confined renal cell carcinomas: no evidence for prognostic significance.

Hofmockel G, Wittmann A, Dammrich J, Bassukas ID.

Anticancer Res. 1996 Nov-Dec;16(6B):3807-11.

PMID:
9042262
[PubMed - indexed for MEDLINE]
14.

Significance of P-glycoprotein, p53, and survivin expression in renal cell carcinoma.

Baytekin F, Tuna B, Mungan U, Aslan G, Yorukoglu K.

Urol Oncol. 2011 Sep-Oct;29(5):502-7. doi: 10.1016/j.urolonc.2009.09.001. Epub 2009 Nov 27.

PMID:
19945306
[PubMed - indexed for MEDLINE]
15.

Cyclooxygenase-2 and p53 expression as prognostic indicators in conventional renal cell carcinoma.

Cho DS, Joo HJ, Oh DK, Kang JH, Kim YS, Lee KB, Kim SJ.

Yonsei Med J. 2005 Feb 28;46(1):133-40.

PMID:
15744816
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

p53 protein expression but not mdm-2 protein expression is associated with rapid tumor cell proliferation and prognosis in renal cell carcinoma.

Moch H, Sauter G, Gasser TC, Buchholz N, Bubendorf L, Richter J, Jiang F, Dellas A, Mihatsch MJ.

Urol Res. 1997;25 Suppl 1:S25-30.

PMID:
9079753
[PubMed - indexed for MEDLINE]
17.

[Clinicopathologic analysis of papillary renal cell carcinoma].

Zhang W, Li YJ.

Zhonghua Zhong Liu Za Zhi. 2010 May;32(5):354-8. Chinese.

PMID:
20723433
[PubMed - indexed for MEDLINE]
18.

Multiple cytokeratin-negative malignant tumors composed only of rhabdoid cells in the renal pelvis: a sarcomatoid urothelial carcinoma?

Terada T.

Int J Clin Exp Pathol. 2013;6(4):724-8. Epub 2013 Mar 15.

PMID:
23573320
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Chromophobe renal cell carcinoma with rhabdoid differentiation in an adult.

Brčić I, Spajić B, Krušlin B.

Wien Klin Wochenschr. 2012 Jun;124(11-12):419-21. doi: 10.1007/s00508-012-0189-y. Epub 2012 Jun 14. Review.

PMID:
22696227
[PubMed - indexed for MEDLINE]
20.

Rhabdoid differentiation of chromophobe renal cell carcinoma.

Shannon BA, Cohen RJ.

Pathology. 2003 Jun;35(3):228-30.

PMID:
14506967
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk